openPR Logo
Press release

Explore Anatomic Pathology Testing Market: Latest Trends and Future Outlook by 2025

07-24-2017 02:12 PM CET | Health & Medicine

Press release from: Transparency Market Research

Explore Anatomic Pathology Testing Market: Latest Trends

Anatomic pathology is a branch of science or branch of medicine that primarily involves microscopic, biochemical, and molecular examination of organs and tissues to find out the effectiveness of diseases. The key objective of anatomic pathology is to identify abnormalities in order to manage diagnosis and treatment. Anatomic pathology helps to detect various types of tumor and cancer. It is also sometimes useful to evaluate the liver and kidney diseases effectively.

Gross examination, histopathology, immunohistochemistry, cytopathology, and flow immunophenotyping are some of the procedures carried out during anatomic pathology test. Anatomic pathology testing is a superspeciality test. To perform this type of test, a person should have a qualified certification from a recognized body such as the American Board of Pathology or the American Osteopathic Board of Pathology. Anatomic pathologist is also involved in post mortem examination. Like clinical pathology reports, anatomic pathology reports also contain essential elements such as name, number, sample type, and source. Many anatomic pathology departments operate according to the specific need of a patient.

Obtain Report Details @ http://www.transparencymarketresearch.com/anatomic-pathology-testing-market.html

The anatomic pathology testing market has been segmented based on product, services, and application. In terms of product, the market has been categorized into instruments and consumables. Instruments such as microscope, centrifuges, slides, and cassette printers are used to conduct anatomic pathology tests. Consumables include kits, reagents, and antibodies. Based on services, the anatomic pathology testing market has been segmented into cytopathology and histopathology. In terms of application, the market has been categorized into breast cancer diagnosis, lung cancer diagnosis, and cervical cancer diagnosis.

Based on end-user, the global anatomic pathology testing market has been segmented into clinical diagnostic laboratories, hospitals, and physician office laboratories. Increasing prevalence of chronic diseases, maximum use of biomarkers, direct to customer facility, and government awareness about early cancer detection and diagnosis are likely to boost the growth of the anatomic pathology testing market. High cost of digital imaging, poor resolution, set up costs, lack of depth perception are some of the factors restraining the market.

Geographically, the anatomic pathology testing market is dominated by North America due to rising incidence of cancer and epathology solutions. Rising prevalence of chronic diseases, rapid increase in geriatric population, and high acceptance of personalized medicine and digital laboratory propel the market in Europe. Growing academic and government investment in diagnostic research and rising awareness about the use of anatomic pathology test among physicians are projected to boost the growth of the market in Asia Pacific.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26852

Increasing globalization, sound economy, and changing lifestyle habits of the population in the region has led to the growth of the anatomy pathology testing market in Latin America. High life expectancy, increasing burden of diseases, increasing chronic and non-communicable diseases such as diabetes, cancer, and obesity fuel the growth of the anatomic pathology testing market. Improving living standards, and increasing demand for quality medicines in Middle East & Africa boost the growth of the anatomy pathology testing market in the region.

Major players in the anatomic pathology testing market are Abbott Diagnostic International Ltd., Agilent Technologies, Danaher, Roche Diagnostics, Bio SB, Neogenomics Laboratories, Inc., and Quest Diagnostics Incorporated.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Explore Anatomic Pathology Testing Market: Latest Trends and Future Outlook by 2025 here

News-ID: 638427 • Views:

More Releases from Transparency Market Research

Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 Billion by 2036 at 5.3% CAGR
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Application | U.S. • Germany • China • India
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million to US$ 1,000.2 Million by 2036 at a 17.0% CAGR
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported by Biopharma Growth
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple

All 5 Releases


More Releases for Anatomic

Anatomic Pathology Market: Trends Shaping the Future of Diagnostics
The global Anatomic Pathology market has witnessed impressive growth over the past few years, with substantial technological advancements, increased diagnostic needs, and a surge in healthcare spending across the globe. The demand for precision medicine, combined with the rise of personalized treatments, has further accelerated the importance of anatomic pathology in diagnosing diseases, particularly cancer, infections, and autoimmune disorders. In this comprehensive report, we will explore the market dynamics, growth
Anatomic Pathology Market Trend And Opportunities By Forecast 2028
According to Premium Market Insights new research study on "Anatomic Pathology Market is expected to grow from US$ 22,800.20 million in 2022 to US$ 33,145.78 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028. Get a Sample Copy of This Report@ https://www.premiummarketinsights.com/sample/TIP00009138/?utm_source=OpenPR&utm_medium=10655 Some Of the Major Players Influencing are F. Hoffmann-La Roche Ltd., Danaher, Hologic, Inc., Agilent Technologies, Inc., BioGenex, Diapath S.p.A., Bio SB,
Anatomic Pathology Market Size, CAGR | Growth - 2030
Exclusive Report by Ameco Research: Anatomic Pathology Market Size Projected to Reach USD 32 Billion by 2030, Growing at 6.50% CAGR Ameco Research is proud to announce the launch of its latest market research report, Anatomic Pathology Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Why Are Diagnostic Laboratories Using Anatomic Pathology Products?
The World Health Organization (WHO) estimates that nearly 1.28 billion people aged 30–79 years are currently living with hypertension, and nearly two-thirds of this population reside in low- and middle-income countries. The organization also reveals that nearly 17.9 million human lives were lost due to cardiovascular diseases (CVDs), such as heart attack and stroke, globally in 2019. Further, the International Agency for Research on Cancer (IARC) states that 19,292,789 people
Anatomic Pathology Market Trends, Size, Forecast - 2019-2025
The global anatomic pathology market is expected to grow at a CAGR of 6%, during the forecast period. Anatomy pathology is the branch of medicines in which the effect of disease on the body organs are studied as a whole or microscopically. The key applications include identification of the abnormalities that aids in diagnosis and managing the treatment of diseases. One of the key applications of the anatomic pathology includes
Global Anatomic Pathology Market Research Report
This report studies the global Anatomic Pathology market status and forecast, categorizes the global Anatomic Pathology market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Agilent Technologies, Inc. Bio SB Biogenex Laboratories Danaher Corporation F. Hoffmann-La Roche AG. Laboratory Corporation of America